GRFS — Grifols SA

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1438569 ·
Last close
$8.63
Market Cap
$2.23B
52W High
$9.64
52W Low
$6.87
ADV30
701,450
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 2,040,000,000 807,000,000 394,000,000 162,000,000 20,281,000,000 486,000,000 12,038,000,000
Jun 2026 1,874,000,000 705,000,000 329,000,000 155,000,000 20,090,000,000 513,000,000 12,110,000,000
Mar 2026 1,700,000,000 620,000,000 249,000,000 73,000,000 20,078,000,000 702,000,000 12,231,000,000
Dec 2025 1,981,660,000 686,841,000 275,377,000 98,250,000 19,712,000,000 801,000,000 12,109,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,117,864,000
Investing CF
$-538,321,000
Financing CF
$-737,176,000
CapEx
$-453,149,000
Dividends Paid
$-187,618,000
Buybacks
—
EPS Diluted TTM
$0.76
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$390,000,000
Inventory
$3,469,000,000
Receivables
$1,079,000,000
ST Investments
$209,000,000
EBIT TTM
$1,188,087,000
Pretax Income TTM
$708,096,000
Interest Exp TTM
$558,421,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$7,421,000,192
EBITDA
$1,645,230,976
Free Cash Flow
$572,923,392
Enterprise Value
$21,529,769,984
Total Cash
$537,000,000
Total Debt
$9,356,000,256
Shares Out
258,223,442
Trailing EPS
$0.77
Book Value
$4.72
ROE
6.9%
ROA
4.2%
Div Yield
3.73%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 7,524,000,000 1,251,000,000 402,000,000 19,712,000,000 12,109,000,000 5,271,000,000 1,047,000,000
Dec 2024 7,212,000,000 1,155,000,000 157,000,000 21,405,000,000 12,799,000,000 5,883,000,000 902,000,000
Dec 2023 6,592,000,000 718,000,000 42,000,000 20,992,103,000 13,478,408,000 5,368,376,000 217,000,000
Dec 2022 6,063,967,000 678,958,000 185,035,000 21,229,584,000 13,253,455,000 5,648,523,000 -1,427,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.44

Max Pain — expiry 2026-12-18

max pain strike: $8.00 · spot: $8.47 · call oi: 2,343 · put oi: 1,579
Expected Move to 2026-12-18: ±$1.08 (12.69%) — implied range $7.40 – $9.55 · ATM straddle on $8.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
LKFT Lakefront Biotherapeutics NV $2.25B $34.39 —
PHVS Pharvaris N.V. $2.27B $32.28 —
PRGO PERRIGO Co plc $2.19B $15.76 —
PBH Prestige Consumer Healthcare Inc. $2.29B $48.22 —
GLPGF Lakefront Biotherapeutics NV $2.30B $35.15 —

News headlines (Yahoo Finance, 1h cache)

European Equities Traded in the US as American Depositary Receipts Advance Sharply in Wednesday Trading
2026-11-04 16:13 · Yahoo
Grifols (BME:GRF) Stock Price Trails Q3 Results As Debt Questions Linger
2026-11-03 19:11 · Yahoo
Grifols Beats Q3 Revenue Forecasts as Immunoglobulin Demand Supports Profit Growth
2026-11-03 11:17 · Yahoo
Grifols SA (GRFS) Q3 2026 Earnings Call Highlights: Biopharma Growth Accelerates as Margin ...
2026-11-03 05:03 · Yahoo
Grifols (GRFS) Q3 2026 Earnings Call Transcript
2026-11-03 03:58 · Yahoo
Grifols Q3 Earnings Call Highlights
2026-11-02 20:12 · Yahoo
Grifols Q3 revenue exceeds estimates as immunoglobulin sales drive growth
2026-11-02 18:20 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
2026-11-02 16:16 · Yahoo
Grifols (BME:GRF) Stock Still Looks Cheap Based On Current Earnings
2026-10-27 06:07 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
2026-10-26 15:12 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.